Company Valuation: Satellos Bioscience Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 6.794 36.73 95.65 89.3 127.6 - -
Change - 440.53% 160.46% -6.65% 42.9% - -
Enterprise Value (EV) 1 6.794 36.73 46.68 89.3 84.91 5.057 -59.59
Change - 440.53% 27.11% 91.29% -4.91% -94.04% -1,278.32%
P/E -0.69x -2.39x -3.32x -3.36x -2.8x -2.59x -2.67x
PBR - - - - 3.27x 3.23x -
PEG - 0.1x -0.1x 0.2x -0.1x -0.33x 0.97x
Capitalization / Revenue - - - - - - 11x
EV / Revenue - - - - - - -5.13x
EV / EBITDA - - - -3.38x -3.4x -0.18x 2.13x
EV / EBIT -1.08x -3.23x -2.4x -3.37x -1.85x -0.09x 0.85x
EV / FCF - - -2.67x - -2.35x -0.12x -
FCF Yield - - -37.5% - -42.6% -867% -
Dividend per Share 3 - - - - - - -
Rate of return - - - - - - -
EPS 3 -3.84 -2.16 -3 -2.354 -3.081 -3.323 -3.231
Distribution rate - - - - - - -
Net sales 1 - - - - - - 11.61
EBITDA 1 - - - -26.46 -25 -27.75 -28
EBIT 1 -6.268 -11.38 -19.45 -26.46 -45.81 -59.48 -70.43
Net income 1 -8.368 -11.69 -19.65 -24.87 -44.03 -66.91 -81.73
Net Debt 1 - - -48.97 - -42.7 -122.6 -187.2
Reference price 3 2.640 5.160 9.960 7.920 8.620 8.620 8.620
Nbr of stocks (in thousands) 3,483 9,399 13,818 15,459 21,216 - -
Announcement Date 30/03/23 27/03/24 26/03/25 27/03/26 - - -
1CAD in Million2USD in Million3CAD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-2.8x - -3.4x - 128M
17.09x6.54x12.53x1.75% 65.45B
31.87x8.51x28.12x0.07% 58.93B
38.62x6.88x20.56x0.84% 55.21B
43.31x6.04x28.76x-.--% 46.1B
33.65x3.22x13.91x-.--% 42.49B
35.05x8.68x22.64x0.37% 35.56B
-18.94x54.62x-20.7x-.--% 34.57B
41.52x8.01x26.86x-.--% 32.46B
-74.21x13.84x-79.52x-.--% 26.28B
Average 14.52x 12.93x 4.98x 0.34% 40B
Weighted average by Cap. 21.51x 11.45x 11.08x 0.45%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Satellos Bioscience Inc.

Historical PBR trend

Valuation ratios - PBR - Satellos Bioscience Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Satellos Bioscience Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Satellos Bioscience Inc.

  1. Stock Market
  2. Stocks
  3. MSCL Stock
  4. Valuation Satellos Bioscience Inc.